info

Reata Pharmaceuticals Inc - Ordinary Shares - Class A

short

$RETA Why are there so many shorts in this room?

$RETA Shorts are desperate- why else are they posting same nonsense over and over on a Saturday!

shorts getting destroyed, almost vertical time! !

$BBBY $LHDX $RETA $TRKA  
 
Shorts are in BIG BIG trouble on $LION right now!!

They just been letting shorts cover all day. Strange.

$RETA cover shorties lol ….not looking good for you

$HHRS 120k FLOAT SHIT IS GOING TO BLOW THE F 🆙 🚨🚨🚨🚨🚨🚨🚨🌟🌟🌟🌟🌟🌟🌟⚡️⚡️⚡️⚡️⚡️⚡️⚡️🔥🔥🔥🔥🔥🔥🔥🔥🔥

SHORTS ARE IN A DEEP HOLE (NAKED ON 120K FLOAT) CRAZY!!!!!!!!

chart

$RETA Looks like the stock is headed for a bull run according to the chart.

$RETA Positive chart for the stock upward trend expected.

$RETA The chart shows potential for significant gains in the stock price.

Chart rock and solid move, stairway to heaven.

$IBRX Both waiting FDA approval, both have similar charts and Similar mkt caps: 
Market Cap 1.055B $RETA Market Cap 1.101B 
 
Short Games played till get FDA approval, gotta love the shakeouts.

$RETA Looks like the stock is headed for a profitable period, according to the chart.

$RETA Bullish pattern building from 44 signals on the 15-min chart.

The security hit the chart high (30.15) in the past 10 minutes.

security

target

$KRTX now a way better m&amp;a target than $MDGL $INCY $VKTX $RETA

$RETA $SPCE $ATUS    Analyst-price target for next week 🚀🚀    bull-target.webglobal.info

$NVAX $RETA $FSLR    Analyst-price target for next week 🚀🚀    bull-target.webglobal.info

$NKLA $RETA $SPCE    Analyst-price target for next week 🚀🚀    bull-target.webglobal.info

$HIMS $WDAY $RETA    Analyst-price target for next week 🚀🚀    bull-target.webglobal.info

$RETA $ZM Analyst price target for today,🚀 best-bullplatform.algotrading.blog

We alerted the BUY signal at $85.37 and we were able to close this one with profit at $89.38 🥳

We alerted the BUY signal at $83.53 and we were able to close this one with profit at $86.43 ✅

Buy every dip and they always goes up been making like 100k so far.

Just buy and hold for the catalysts sole US listing next week.

We alerted the BUY signal at $82.36 and we were able to close this one with profit at $84.81 🎯

We alerted the BUY signal at $81.72 and we were able to close this one with profit at $84.69 🔏

$RETA buy now and be a bag holder later ⚠️⚠️⚠️⚠️⚠️⚠️⚠️

Buy, hold, and prosper greatly over the next few months.

Velo3D Inc - Ordinary Shares - New

production

but is still minuscule compared to the overall metal parts manufacturing space.

They generally don’t have the ability to produce parts with the complexity AND IMPORTANTLY, THE QUALITY that is required in the types of applications that I’ve described.

They gave 2 factors for the revenue/earnings/margin miss…the continued supply chain problems AND the production problems associated with this new model.

They don’t have the ability to produce parts with the complexity and importantly, the quality that are required in the types of applications that I’ve described.

And besides China&#39;s Zero Covid policy (lock-downs, workers not producing the parts and/or sub-assemblies that Velo needs), there is the friction between the 2 governments.

supply

but their only main issue is the supply chain as demand/backlog is there?

but would have had a significant beat on revenue if not for supply chain problems that prevented the receipt of electronics needed for sub-assemblies.

The miss in Q3 was the result of supply chain and there manager has been fired.

but a high qualty, &quot;transitory&quot; supply problem.

$VLD IMO the only issue velo can run into with its ER is not being able to get the parts to build their printers bc of supply chain… what are y’all thoughts ?

technology

Their machines form the foundation of our company’s manufacturing technology, and we are thrilled to be part of this milestone achievement in EOS’ history.“

This year alone has already seen multiple advances from companies and start-ups active in this field who have harnessed 3D printing technologies for the design and production of their products.

Additionally, VELO3D&#39;s SupportFree printing technology eliminates the need for support structures during the printing process, which can reduce the likelihood of errors and increase the efficiency of the printing process.

Additionally, the company&#39;s innovative technology and AI-powered software could further differentiate it from other 3D printing companies.

We believe Velo’s unique technology and software solutions will drive strong growth, especially as the Sapphire XC system, with its larger print volume, continues to penetrate the market for complex metal parts.&quot;

industry

$VLD Mr Buller is out there spreading knowledge and promoting both the industry and the company, very good.

The company’s solution unlocks a wide breadth of design freedom and enables customers in space exploration, aviation, power generation, energy and semiconductor to innovate the future in their respective industries.

First, our European expansion is going well as we booked to industry leading EU aerospace customers in Q3.

Qualifying this material is a game changer for the automotive and tooling industry as it enables production of high quality die cast tooling with a geometrical flexibility that has not been possible before.

1) The early stages of a great technology that can impact multiple industries and become a major sector in itself 
 
2) A customer base that includes SpaceX and Raytheon.

I’m thrilled to join such an innovative company that is transforming so many important industries in meaningful ways,” Kreger said.

This advantage is reflected in our strong growth since 2018 as well as our customer base, which boasts the leaders in space, aerospace, energy, and contract manufacturing industries.

But I like that they have a true moat and people like me in the aerospace industry are willing to pay big money for that.”

growth

Still love the company and future growth.

This would be a significant share of the market, and would require substantial growth in the coming years.

market

PK8886 
PK 
@PK8886 
 
Jan 14, 2022 9:24 AM 
 
$TWST Possibly the best buy in the stock market right now.

Sign up today and start receiving expert insights on potential market opportunities 
 
📈FREE trade-of-week via(Google Search) ⟶  𝐟𝐫𝐞𝐞𝐚𝐥𝐞𝐫𝐭.𝐩𝐰

$VLD one of the only stocks pushing against bear.. imagine when market turns bull again!

Biocryst Pharmaceuticals Inc.

trading

$XBI $BCRX XBI trading at 2017 prices holy fuck

$BCRX Jon should have been investigated for insider trading and his pulled offering and his many many misleading statements of embezzlement of riches!

Don’t fall for their bullshit, let the dogs trade with themselves

Big Loser Alert: Trading today&#39;s -8.4% move in BIOCRYST PHARMACEUTICALS $BCRX https://wp.me/p5bLGB-iCRZ

You might have lost money on every trade and every move.

but the trading, at least in my mind, seems a bit strange, and a bit like its percolating,  and something is brewing, such as 9930 prelim data, or some other pr drop is coming.

$BCRX the options pricing on this ticker trading in five cent increments really chaps my ass.

Shorting like this should be 100% illegal in my opinion and falls under manipulation of fair trading!

executive

$BCRX  
 
man ceo scamhouse sucks royal ass 
 
lying prick 
 
💩💩💩💩💩

too bad $bcrx has that chicken shit ceo scamhouse.

if anyone in $xbi $ibb are looking for a bio with a pos lying scumbag ceo then look at 
 
$BCRX 
 
one of the worst anywhere 
 
thank me later

Board needs to act as ceo has mislead his shareholders deceitful action!

Your CEO and board are lightweight morons and your shares will continue to lose value.

$BCRX “what’s the value of that” - Jack shit When You’re CEO

Your CEO and board are fucking idiots who had a solid hand

Their fucking shares are underwater because you’re a shit CEO

premium

We have no premium because Stoney is a dumb cunt.

NOW EVEN WITH NEARLY 300M IN FUCKING REVS THESE WORTHLESS FUCKS ON THE BOD CANT GET ANYTHING DONE EXCEPT SPEND TONS OF CASH ON USELESS SHIT PROGRAMS IN THE PIPE INSTEAD OF MAKING US PROFITABLE WITH WHAT THEY HAVE AN SELLING AT A PREMIUM.

but saw the .47/per - even higher premium than my $13s!

$BCRX disappointing price action over the last 3 days, the only reason why this doesn’t bother me so much is the call premium!

loss

$BCRX Took a 50k loss, I’m the fuck outta here.

You played people here all while you lined your pocket with their losses!

$BCRX For the first time in over 2 years I might be setting a stop loss on my remaining position, dang it

$BCRX Investing in Biotech should come with a WARNING:
Will cause hair loss, vomiting, Insomnia and alcohol addiction lol

When it’s bad, it’s very bad.

That is a loss of just 18 to 19% for a VERY volatile bio market sector in a historically VERY shitty bear market.

$BCRX looks like EOY will not be very good.. 13,75 it was 31-12-2021.. now we are at 10,65.. looks like 2022 will end with a pretty big YTY loss

$BCRX this stock is as frustrating as that Spain loss 😤

Carvana swung to an adjusted operating loss of $186 million compared to a $9 million profit a year ago.

YOU MORONS HAVEN’T DONE YOUR JOB THE PAST 2 YEARS IN FORCING STONEHOUSE’S HAND FOR A BUYOUT.

Or sell the damn company and let a real Pharma with real leadership do the job.

Btw they are doing a crappy job trying to play up the new compound, cuz it’s to early.

$BCRX damn its like they knew i was gone and didn&#39;t do SHIT jobs wise

$BCRX This is actually a good buy at these levels.

data

$BCRX  
European stocks rose on Friday as investors took an optimistic view of a week of data releases that showed economies in Europe and the US were more robust than expected.

#1 Suddenly alot of positive accounts appear, promoting the company has solid data, solid sales

$BCRX Have strong feeling once 10013 data is out we are going places.

$BCRX This preliminary data on BCX10013 is pretty impressive.

$BCRX great 10013 data and 320+ projected rev

but it also seems like the good choice to do so seeing iptacopan data.

business-result

Long term Bcrx should climb quarter after quarter until they align with projections billion plus!

Positive news with the early results of the new Factor D molecule 10013.

$BCRX 10% growth quarter over quarter considering flat q1 (as noted with ins payout sched) puts us at 326mil for the year.

Relative strength to SPY past 6 weeks, high growth 8 quarters straight.

$BCRX 10.5 is the new high for this first quarter.

$BCRX so they hit their Q4 numbers, had stellar phase IA results and guided for a 70Mil increase in revenue in 202e.

$BCRX sales doubled 4 quarter 70.7 million + 53% year over year..

Result - volume up about 36.5% over a normal day.

But, with our management, our scientists, and our derisked ORLADEYO keeping the revenues incoming and growing quarter after quarter after quarter.

Prem results in q1 and it will beat any drug in the mkt.

hold

My strat is way better then hold and get rich 😉

$BCRX  I&#39;ve really enjoyed this forum - going to hold at least my current 18k shares, forever.

Top Stocks matching your search for "inside info"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

RETA

Reata Pharmaceuticals Inc - Ordinary Shares - Class A

75.36%

$49.03 - $85.98

Mar, 1, 2023

VLD

Velo3D Inc - Ordinary Shares - New

-30.53%

$3.21 - $2.23

Jan, 4, 2023

BCRX

Biocryst Pharmaceuticals Inc.

-23.50%

$10.68 - $8.17

Dec, 13, 2022

RETA

Reata Pharmaceuticals Inc - Ordinary Shares - Class A

75.36%

$49.03 - $85.98

Mar, 1, 2023

VLD

Velo3D Inc - Ordinary Shares - New

-30.53%

$3.21 - $2.23

Jan, 4, 2023

BCRX

Biocryst Pharmaceuticals Inc.

-23.50%

$10.68 - $8.17

Dec, 13, 2022